Cardiovascular Journal of Africa: Vol 25 No 6 (November/December 2014)

8 / 66

CARDIOVASCULAR JOURNAL OF AFRICA • Volume 25, No 6, November/December 2014 258 AFRICA
D. The burden of non-communicable diseases in South Africa. Lancet
2009; 374: 934–947.
13. Mayosi BM, Lawn JE, van Niekerk A, et al. Health in South Africa:
changes and challenges since 2009. Lancet 2012; 380: 2029–2043.
14. Sliwa K, Wilkinson D, Hansen C, Ntyintyane L, Tibazarwa K, Becker
A, Stewart S. Spectrum of heart disease and risk factors in a black urban
population in South Africa (the Heart of Soweto Study): a cohort study.
Lancet 2008; 371: 915–922.
15. Tibazarwa K, Ntyintyane L, Sliwa K, Gerntholtz T, Carrington M,
Wilkinson D, Stewart S. A time bomb of cardiovascular risk factors in
South Africa: results from the Heart of Soweto Study ‘Heart Awareness
Days’. Int J Cardiol 2009; 132: 233–239.
16. Alsheikh-Ali AA, Omar MI, Raal FJ, Rashed W, Hamoui O, Kane A,
Alami M, Abreu P, Mashhoud WM. Cardiovascular risk factor burden
in Africa and the Middle East: the Africa Middle East Cardiovascular
Epidemiological (ACE) study. PLoS One 2014; 9(8): e102830. doi:
10.1371/journal.pone.0102830. eCollection 2014.
17. Kengne AP1, June-Rose McHiza Z, Amoah AG, Mbanya JC.
Cardiovascular diseases and diabetes as economic and developmental
challenges in Africa. Prog Cardiovasc Dis 2013; 56(3): 302–313. doi:
10.1016/j.pcad.2013.10.011.
18. Mondo CK, Otim MA, Akol G, Musoke R, Orem J. The prevalence
and distribution of non-communicable diseases and their risk factors
in Kasese district, Uganda. Cardiovasc J Afr 2013; 24(3): 52–57. doi:
10.5830/CVJA-2012-081.
19. Miszkurka M, Haddad S, Langlois EV, Freeman EE, Kouanda S,
Zunzunegui MV. Heavy burden of non-communicable diseases at
early age and gender disparities in an adult population of Burkina
Faso: World Health Survey. BMC Public Health 2012; 12: 24. doi:
10.1186/1471-2458-12-24.
20. Rejeb J, Omezzine A, Boumaiza I, Rebhi L, Kalboussi N, Laouini A, et
al. Metabolic syndrome is a risk factor for coronary artery disease in a
tunisian population. Metab Syndr Related Disord 2010; 8(2): 105–112.
21. Smith SC Jr, Collins A, Ferrari R, Holmes DR Jr, Logstrup S, McGhie
DV, et al; World Heart Federation; American Heart Association;
American College of Cardiology Foundation; European Heart Network;
European Society of Cardiology. Our time: a call to save preventable
death from cardiovascular disease (heart disease and stroke). J Am Coll
Cardiol 2012; 60(22): 2343–2348. doi: 10.1016/j.jacc.2012.08.962. Epub
2012 Sep 18.
22. Zoghbi WA, Duncan T, Antman E, Barbosa M, Champagne B, Chen
D, et al. Sustainable development goals and the future of cardiovascular
health: a statement from the Global Cardiovascular Disease Taskforce.
J Am Heart Assoc 2014; 3(5): e000504. doi: 10.1161/JAHA.114.000504.
23. 2013 ESC guidelines on the management of stable coronary artery
disease: the task force on the management of stable coronary artery
disease of the European Society of Cardiology. Task Force Members,
Montalescot G, Sechtem U, Achenbach S, Andreotti F, Arden C,
Budaj A, et al.; ESC Committee for Practice Guidelines, Zamorano
JL, Achenbach S, Baumgartner H, Bax JJ, Bueno H, Dean Vet al.;
Document reviewers, Knuuti J, Valgimigli M, Bueno H, Claeys MJ,
Donner-Banzhoff N, Erol C, et al. Eur Heart J 2013; 34(38): 2949–3003.
doi: 10.1093/eurheartj/eht296. PMID: 23996286.
24. O’Gara PT, Kushner FG, Ascheim DD, Casey DE Jr, Chung MK,
de Lemos JA, et al. 2013 ACCF/AHA guideline for the management
of ST-elevation myocardial infarction: executive summary: a report
of the American College of Cardiology Foundation/American Heart
Association task force on practice guidelines. Circulation 2013: published
online before print December 17, 2012, 10.1161/CIR.0b013e3182742c84.
25. Windecker S, Hernández-Antolín R-M, Stefanini GG, Wijns W,
Zamorano JL. Management of ST-elevation myocardial infarction
according to European and American guidelines. EuroIntervention 2014;
10-T23-T31.
26. Silber S. [Evidence-based management of ST-segment elevation myocar-
dial infarction (STEMI). Latest guidelines of the European Society
of Cardiology (ESC) 2010]. Herz 2010; 35(8): 558–564. doi: 10.1007/
s00059-010-3401-8.
27. Harker M, Carville S, Henderson R, Gray H; guideline development
group. Key recommendations and evidence from the NICE guideline
for the acute management of ST-segment-elevation myocardial infarc-
tion. Heart 2014; 100(7): 536–543. doi: 10.1136/heartjnl-2013-304717.
Epub 2013 Sep 5.
28. Bagai A, Dangas GD, Stone GW, Granger CB. Reperfusion strategies
in acute coronary syndromes. Circ Res 2014; 114(12): 1918–1928. doi:
10.1161/CIRCRESAHA.114.302744.
29. Halvorsen S. STEMI treatment in areas remote from primary PCI
centres. EuroIntervention 2012; 8: 44–50.
30. Ranasinghe I, Turnbull F, Tonkin A, Clark RA, Coffee N, Brieger
D. Comparative effectiveness of population interventions to improve
access to reperfusion for ST-segment-elevation myocardial infarction
in Australia. Circ Cardiovasc Qual Outcomes 2012; 5(4): 429–436. doi:
10.1161/CIRCOUTCOMES.112.965111.
31. Antman EM. Time is muscle. Translation into practice. J Am Coll
Cardiol 2008; 52: 1216–1221.